Evidence map›Paper›PMID 41141096›Full record

ArticleCureus2025

Early Structural Deterioration of a Self-Expanding Transcatheter Aortic Valve Prosthesis Presenting With Severe Aortic Insufficiency: A Case Report.

Pranali R Dave, Melkon Hacobian

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Pranali R DaveMedical School, California University of Science and Medicine, Colton, USA.
Melkon HacobianCardiology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transcatheter aortic valve replacement has become an established therapy for severe aortic stenosis, demonstrating prosthesis durability for at least five years (and up to eight years) in recent studies. Structural valve deterioration within 5 years is rare, particularly with self-expanding Evolut prostheses. We present an 88-year-old man with prior coronary artery bypass grafting and severe aortic stenosis who underwent transfemoral transcatheter aortic valve replacement with a 34 mm Evolut valve in 2019. Five years later, he developed progressive dyspnea and chest pain. Examination revealed a grade IV/VI decrescendo diastolic murmur and a markedly wide pulse pressure, raising concern for severe aortic regurgitation. Transesophageal echocardiography demonstrated moderate to severe aortic insufficiency. Coronary angiography revealed patent grafts, without new obstructive native coronary disease. He underwent surgical aortic valve replacement with an Inspiris Resilia bioprosthesis. This case underscores the possibility of rapid prosthetic valve failure and highlights the ongoing importance of physical examination in detecting severe regurgitation. It also contributes to the growing literature on early valve degeneration.

Indexed as

bioprosthetic valve failuresevere aortic regurgitationstructural valve deteriorationtavr (transcatheter aortic valve replacement)tavr valve explantation

Identifiers

PMID41141096
PMCPMC12545629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.